More Drugmakers Exempt New States from 340B Contract Pharmacy Restrictions

Sanofi was one of three drug manufacturers to recently update its contract pharmacy restrictions in response to new state laws.
Pharmaceutical manufacturers Sanofi, GlaxoSmithKline (GSK) and Viatris are fully or partially exempting additional states from their 340B contract pharmacy restrictions. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

U.S. Government, 340B Provider Groups Urge Appeals Court to Reverse Dismissal of Health System’s 340B Whistleblower Lawsuit

Adventist Health System/West's 340B whistleblower lawsuit received four amicus briefs in support of its appeal to the U.S. 9th Circuit Court of Appeals.
The U.S. government is urging a federal appeals court to dismiss a lower court’s “erroneous” decision to dismiss a California [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Bill Introduced to Extend 340B Eligibility to Qualifying Hospitals in U.S. Territories

Del. Gregorio Kilili Camacho Sablan (D), the at-large delegate for the Northern Mariana Islands, introduced a 340B eligibility bill for the U.S. territories.
New legislation introduced in the U.S. House of Representatives would extend 340B program eligibility to qualifying hospitals in all five [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Bipartisan Federal Children’s Healthcare Bill with 340B Reporting Requirements Nears House Vote

The U.S. House passed a bipartisan bill Tuesday evening to streamline Medicaid enrollment for pediatric providers that would also increase reporting requirements for certain 340B providers.
Federal lawmakers may soon vote on a bipartisan bill to streamline Medicaid enrollment for pediatric providers that would also require [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AHA, RWC-340B Ramp Up Critiques of ASAP 340B-Backed Bill

AHA and RWC-340B again took aim at the 340B ACCESS Act introduced this spring.
Two major national 340B provider advocacy groups are stepping up their criticisms of the 340B ACCESS Act, arguing that the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Two Hospitals Sue HRSA to Block ‘Unlawfully Authorized’ Drugmaker 340B Program Audits

Oregon Health & Science University Hospital is one of two 340B hospitals to sue HRSA over approving a drugmaker audit. (Photo by M.O. Stevens)
Two 340B hospitals urged a federal district court to block drugmaker Johnson & Johnson (J&J) from conducting “unlawfully authorized” audits [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Exclusive

Merck, Wisconsin Health System Join 340B Working Table; 300+ Firms Lobbied on 340B in Q2

Merck and Marshfield Clinic Health System have joined the growing list of organizations in the 340B Working Table.
New Jersey-based drug manufacturing giant Merck and a large Wisconsin-based health system are the latest to join the 340B Working [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Just Days After Legal Setback, Novartis Exempts Mississippi Providers From Contract Pharmacy Restrictions

Novartis exempted Mississippi 340B providers from its contract pharmacy restrictions following a new state law.
Just days after a federal court in Mississippi denied Novartis’ attempt to block the state’s 340B contract pharmacy access law, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Health System Urges Federal Appeals Court to Revive 340B Overcharge Lawsuit Against Major Drugmakers

Adventist Health System/West alleged in a lawsuit that four major drugmakers defrauded the federal government by overcharging for 340B drugs.
A California health system has urged a federal appeals court to reverse a lower court’s decision to dismiss its lawsuit [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Merck, Jazz Pharmaceuticals Exempt States from 340B Contract Pharmacy Restrictions — Including First for Missouri

Merck became the first drugmaker to announce it would loosen its 340B contract pharmacy restrictions in Missouri in response to a new state law.
Merck will loosen its 340B contract pharmacy restrictions in Minnesota and Missouri, becoming the first drugmaker to officially update its [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live